Skip to content
Screener

Merit Medical Systems MMSI Q2 2026 earnings

Reported July 30, 2026 · After market close

Revenue$418.8MBeat by $13.6M
EPS$1.19Beat by $0.23
Revenue estimate$405.2M
EPS estimate$0.96
“We experienced improving revenue growth trends across our global business in Q2, as expected, with notable strength in sales to customers in the U.S. which increased 10% year-over-year, well ahead of our expectations. We also delivered improvement in both our non-GAAP operating margin and our non-GAAP earnings per share, which increased by 140 basis points and 18%, respectively, year-over-year.”
Martha G. Aronson

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$418.8M+9.5%
Gross profit$215.2M+16.6%
Operating income$60.4M+28.8%
Net income$38.8M+19.1%
EPS (diluted)$0.65+20.4%

Balance sheet

See full
Cash & equivalents$448.7M+31.3%
Total debt$820.1M-0.1%
Total equity$1.7B+12.9%
Total assets$2.9B+10.7%

Cash flow

See full
Operating cash flow$69.3M-16.8%
CapEx$17.3M+26.0%
Free cash flow$51.9M-25.3%

Valuation & ratios

Valuation

as of 06/30/26
See full
Market cap$4.14B-25.0%
Enterprise value$4.51B-24.7%
P/E28.4×-17.9×
P/S2.6×-1.2×

Profitability

See full
Gross margin49.5%+1.6pp
Operating margin12.8%+1.5pp
Net margin9.2%+0.9pp
FCF margin12.9%-0.6pp

Returns & leverage

See full
Return on equity9.2%+0.6pp
Debt / equity0.5×-0.1×
Current ratio4.2×+0.1×

Segments

By product

See full
Foundational Access$161.8M—
Foundational Original Equipment Manufacturer$48.3M—
Foundational Vascular Intervention$41.7M—
Therapeutic Vascular Intervention$34.4M—
Therapeutic Cardiac Therapies$28.5M—

By segment

See full
Single Reportable$418.8M—

FAQ

When did Merit Medical Systems report Q2 2026 earnings?
Merit Medical Systems (MMSI) reported Q2 2026 earnings on July 30, 2026 after market close.
What were Merit Medical Systems's Q2 2026 revenue and EPS?
Merit Medical Systems reported revenue of $418.8M and eps of $1.19 for Q2 2026.
Did Merit Medical Systems beat estimates in Q2 2026?
Revenue beat the consensus estimate of $405.2M by $13.6M. EPS beat the consensus estimate of $0.96 by $0.23.
How did Merit Medical Systems's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.5% from $382.5M a year earlier and eps grew 17.8% from $1.01.
Where can I find Merit Medical Systems's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000856982-26-000042) and the 10-Q periodic report (0000856982-26-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.